Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05229952 · ClinicalTrials.gov registry record · NA
Assessment of Endogenous Oxalate Synthesis
A NA study of Healthy and Obesity, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT05229952: Completed NA study of Healthy and Obesity, sponsored by University of Alabama at Birmingham.
NCT05229952 is a NA study of Healthy and Obesity that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 23 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05229952, a NA study of Healthy and Obesity, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine the daily rate of endogenous synthesis of oxalate using carbon 13 oxalate isotope tracer technique and a low-oxalate controlled diet.
Primary Outcome
Daily oxalate synthesis rate (mg/day) determined by the 13c2-oxalate infusion method
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Low-oxalate controlled diet
- OTHER Primed, continuous intravenous infusion of 13C2-oxalate
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-02-10 |
| Est. Completion | 2024-09-09 |
| Phase | NA |
What the finished NCT05229952 record still lists
NCT05229952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Low-oxalate controlled diet is the first listed.
NCT05229952 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05229952 about?
NCT05229952 is a clinical study titled "Assessment of Endogenous Oxalate Synthesis". This study aims to determine the daily rate of endogenous synthesis of oxalate using carbon 13 oxalate isotope tracer technique and a low-oxalate controlled diet.
What is the current status of trial NCT05229952?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-02-10. Estimated completion is 2024-09-09.
What conditions does trial NCT05229952 study?
This clinical trial studies the following conditions: Healthy, Obesity, Kidney Stone.
What interventions are being tested in trial NCT05229952?
The interventions under investigation include: Low-oxalate controlled diet (DIETARY_SUPPLEMENT), Primed, continuous intravenous infusion of 13C2-oxalate (OTHER).
Who is sponsoring clinical trial NCT05229952?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05229952 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05229952's enrollment target sits among peer trials
23 838th of 1090 higher than 248 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI